Hylomorph is a Medtech Startup company, spin-off of the Swiss Federal Institute of Technology.
We specialize in cutting-edge combination of micro-engineering and biotechnology into innovative biomaterials for healthcare products.
Hylomorph's core technology optimizes the interface between implantable medical devices and the biological tissues.
Our headquarter is based at Technopark Zurich, in the heart of Switzerland
BOARD OF DIRECTORS
AWARDS AND SUPPORT
Co-funded by the Horizon 2020 programme of the European Union